Statements (44)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:drug
|
| gptkbp:approves |
gptkb:2004
|
| gptkbp:brand |
gptkb:Lyrica
|
| gptkbp:category |
gptkb:C
|
| gptkbp:clinical_trial |
ongoing
|
| gptkbp:contraindication |
hypersensitivity to pregabalin
|
| gptkbp:dosage_form |
75 mg
600 mg 150 mg 300 mg |
| gptkbp:excretion |
urine
|
| gptkbp:form |
gptkb:beer
|
| https://www.w3.org/2000/01/rdf-schema#label |
Lyrica Capsules
|
| gptkbp:indication |
anxiety disorders
generalized anxiety disorder postherpetic neuralgia |
| gptkbp:ingredients |
pregabalin
C8 H17 N O2 |
| gptkbp:interacts_with |
gptkb:beer
benzodiazepines opioids |
| gptkbp:is_atype_of |
N03 A X16
|
| gptkbp:is_used_for |
seizures
fibromyalgia neuropathic pain |
| gptkbp:legal_issue |
prescription only
|
| gptkbp:lifespan |
6.3 hours
|
| gptkbp:manager |
oral
|
| gptkbp:manufacturer |
gptkb:Pfizer
|
| gptkbp:metabolism |
renal
|
| gptkbp:packaging |
blister pack
|
| gptkbp:population |
take with or without food
monitor for mood changes do not stop abruptly may cause withdrawal symptoms avoid driving until you know how it affects you |
| gptkbp:side_effect |
dizziness
drowsiness dry mouth weight gain blurred vision |
| gptkbp:weight |
159.23 g/mol
|
| gptkbp:bfsParent |
gptkb:Pregabalin
|
| gptkbp:bfsLayer |
7
|